HCP, Inc. (NYSE: HCP) reported Q2 FFO of $0.74, $0.04 better than the analyst estimate of $0.70. Revenue for the quarter came in at $662.2 million versus the consensus estimate of $635.14 million.

GUIDANCE:

HCP, Inc. sees FY2016 FFO of $2.83-$2.89, versus the consensus of $2.77.

For earnings history and earnings-related data on HCP, Inc. (HCP) click here.